FDA Moves to Pull Avastin Breast Cancer Approval

Links shared publicly online about this topic.

  • 648
    total visits

FDA Moves to Pull Avastin Breast Cancer Approval

webmd.com

The FDA has moved to withdraw its approval of Avastin for treating metastatic breast cancer. Avastin is still approved for other cancers. Roche/Genentech will fight the decision at an FDA hearing.

View full resource at webmd.com

Tags: Cancer, Breast Cancer, Metastatic Breast Cancer, Colorectal Cancer Medication, Women's Health, FDA, Avastin

  • Share

Most Recently Shared on December 17, 2010 at 2:56 pm By:

WebMD_Cancer WebMD Cancer

FDA Moves to Pull Avastin Breast Cancer Approval http://bit.ly/hvaepP

1 year ago...

Also Shared By:

WebMD WebMD

New Avastin tests add to confusion over use in breast cancer - latimes.com

latimes.com — “After the FDA pulled its approval for Avastin in metastatic breast cancer cases in November, a couple of new studies offer hints of hope for its use in early-stage breast cancer.View full resource at latimes.com

  • View Related
  • Share

Most Recently Shared on January 28, 2012 at 3:09 am By:

BrstCancerNews Breast Cancer News Health News

Google News: New Avastin tests add to confusion over use in breast cancer - Los Angeles: http://t.co/U49t1gMv Full http://t.co/sJPQq0Rn

3 months ago...

FDA Pulls Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR

npr.org — “After more than a year of deliberations and an unprecedented public hearing in June, the agency has revoked approval of the biotech blockbuster Avastin, a medicine that chokes off the blood supply to various cancer cells, as a treatment for metastatic breast cancer.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on November 25, 2011 at 8:15 pm By:

ClevelandClinic Cleveland Clinic Healthcare System

FDA Pulls Approval Of Avastin For Breast Cancer, Dr. Sekeres weighs in. http://t.co/pKxnsPEt @nprhealth

6 months ago...

Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says - Businessweek

businessweek.com — “U.S. regulators revoked approval of Roche AG’s Avastin as a treatment for metastatic breast cancer, a move the drugmaker has said could put as much as 800 million Swiss francs ($873 million) in revenue at risk.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on November 24, 2011 at 1:49 am By:

Cancer_Wisdom Cancer OW OW Health

Roche’s Avastin Revoked for Use in Breast Cancer, FDA Says: U.S. regulators revoked approval of Roche AG’s Avast... http://t.co/wiOduoUi

6 months ago...

FDA's Avastin decision sends breast cancer patients reeling - HealthPop - CBS News

cbsnews.com — “Agency pulls blockbuster drug's approval for breast cancer, saying evidence doesn't confirm benefit Read more by David W Freeman on CBS News' HealthPop.View full resource at cbsnews.com

  • View Related
  • Share

Most Recently Shared on November 19, 2011 at 6:03 am By:

FDA rejects Avastin for use against metastatic breast cancer – The Chart - CNN.com Blogs

thechart.blogs.cnn.com — “The Food and Drug Administration announced Friday that it was revoking its approval of the drug Avastin for metastatic breast cancer after concluding that it has not been shown to be safe and effective for that use.View full resource at thechart.blogs.cnn.com

  • View Related
  • Share

Most Recently Shared on November 18, 2011 at 8:21 pm By:

FDA Commissioner announces Avastin decision

fda.gov — “FDA Commissioner Margaret A. Hamburg, M.D., said today she is revoking the agency’s approval of the breast cancer indication for Avastin (bevacizumab) after concluding that the drug has not been shown to be safe and effective for that use.View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on November 18, 2011 at 3:38 pm By:

strataderm Strataderm for Scars Health Social Media and Pharma

FDA revokes approval of Avastin for breast cancer, drug not shown to be safe and effective in breast #cancer patients http://t.co/jpnkqr6q

6 months ago...

Pushing the envelope : Nature Biotechnology : Nature Publishing Group

nature.com — “The US Food and Drug Administration (FDA) should follow its advisory panels and rescind metastatic breast cancer from Avastin's label.View full resource at nature.com

  • View Related
  • Share

Most Recently Shared on August 8, 2011 at 6:57 pm By:

FiercePharma FiercePharma Health Site

More on Avastin breast cancer use in Nature Biotech: If FDA doesn't pull it, fast-track approval will lose credibility. http://bit.ly/nMFiAP

9 months ago...

Expert Panel Tells FDA To Pull Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR

npr.org — “Genentech failed to persuade a single member of the Food and Drug Administration's panel of cancer experts that its blockbuster drug Avastin should keep the agency's seal of approval for treating advanced breast cancer.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 6:15 pm By:

PhysiciansPract Physicians Practice Medical Journal

Genentech fails to persuade any members of #FDA panel to approve Avastin for breast cancer treatment (@nprhealth) http://n.pr/jurtgL

10 months ago...

A.M. Vitals: FDA Panel Recommends Pulling Avastin’s Breast-Cancer Approval - Health Blog - WSJ

blogs.wsj.com — “Also: Fenugreek seeds implicated in E. coli outbreak; appeals court upholds health-care overhaul law; lower-rated hospital bonds are punished.View full resource at blogs.wsj.com

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 1:01 pm By:

FightCancer FightCancer Health News

A.M. Vitals: FDA Panel Recommends Pulling Avastin’s Breast-Cancer Approval http://on.wsj.com/iLTyBR

10 months ago...

Expert Panel Tells FDA To Pull Approval Of Avastin For Breast Cancer : Shots - Health Blog : NPR

npr.org — “Genentech failed to persuade a single member of the Food and Drug Administration's panel of cancer experts that its blockbuster drug Avastin should keep the agency's seal of approval for treating advanced breast cancer.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on June 29, 2011 at 9:53 pm By:

NickCharles507 Nick Charles Health Marketing

Expert Panel Tells FDA To Pull Approval Of Avastin For Breast Cancer: Genentech failed to persuade a sing... http://n.pr/jK7pZ7 from NPR

10 months ago...

Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR

npr.org — “In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients and the drug's maker.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on June 29, 2011 at 2:31 pm By:

hrana Hisham Rana, MD Doctor and Physician

Commentary: Avastin as breast #cancer treatment tests US #FDA's ability to say no http://n.pr/lLx8Cu - Well said: "Do data matter?" #health

10 months ago...

Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No : Shots - Health Blog : NPR

npr.org — “In a controversial 2008 decision, the FDA gave a fast-track approval for the pricey drug for breast cancer treatment based on a single study. Now, after subsequent research proved disappointing, the agency is moving to revoke the approval, angering patients and the drug's maker.View full resource at npr.org

  • View Related
  • Share

Most Recently Shared on June 29, 2011 at 2:03 pm By:

NPRHealth NPR Health News Health News

From @dickknox: Avastin As Breast Cancer Treatment Tests FDA's Ability To Say No http://n.pr/koGuyf

10 months ago...

FDA Revokes Approval for Breast Cancer Drug

healthbistro.lifescript.com — “In what many feel is a sign of the times to come, the Food and Drug Administration (FDA) has moved to revoke regulatory approval for Avastin, an innovative biotech treatment for metastatic breast cancer. The FDA announced that the risksView full resource at healthbistro.lifescript.com

  • View Related
  • Share

Most Recently Shared on December 27, 2010 at 10:38 am By:

LifeScript LifeScript Health Site

FDA Revokes Approval for Breast Cancer Drug http://bit.ly/gZvLAW

1 year ago...

GoErie.com: Health - Health news in brief

goerie.com — “The Food and Drug Administration Thursday took the first step toward revoking approval of the blockbuster cancer drug Avastin for use against breast cancer -- an approval initially given under a special accelerated evaluation process that was always subject to review. Regulators pointed to four recent studies that showed Avastin did not prolong the lives of breast cancer patients. Janet Woodcock, head of FDA's drug approval office, said the agency was moving away from its earlier approval of AvaView full resource at goerie.com

  • View Related
  • Share

Most Recently Shared on December 20, 2010 at 10:07 am By:

Health_News_OW Health News OW OW Health

Health news in brief: The Food and Drug Administration Thursday took the first step toward revoking approval of ... http://bit.ly/fA6MEQ

1 year ago...

Advertisement